Statistical Significance versus Clinical Relevance: Key Considerations in Interpretation Medical Research Data

Abstract

Medical research plays a crucial role in advancing our understanding of various aspects related to health, including disease, risk factors, and patient management. However, the interpretation of research data becomes intricate when considering the notions of statistical significance and clinical relevance. It is not uncommon to interpret findings that demonstrate statistical significance as indicative of clinical relevance. To explain it in a more straightforward way, statistical significance, ascertained through statistical tests using the P value, indicates that an observed difference or association is improbable to occur by chance alone. Conversely, clinical relevance focuses on the practical implications of a finding in real-world contexts and determines whether an observed difference or relationship holds practical meaning. Recently, there have been issues and debates surrounding the idea of statistical significance as certain experts argue that its mathematical representation can be misleading when it comes to practical understanding. These experts propose the inclusion of additional measures like effect sizes and confidence intervals. A sound comprehension of both statistical and clinical dimensions is vital in order to ensure precise interpretation of data and facilitate well-informed decision-making in the practice of medicine. By doing so, it positively influences the health of individuals and communities.

INTRODUCTION

Medical research plays a crucial role in advancing our knowledge of diseases, risk factors, treatments, and patient outcomes.[1] However, interpreting research data can be complex, especially when dealing with reconciling statistical significance and clinical relevance in the ever-changing world of biomedical literature within evidence-based medicine.[2] In this article, we explore the similarities, distinctions, controversies, and consequences of these two vital aspects of data interpretation in medical research.

When analyzing research data and drawing conclusions, it is crucial to consider both statistical significance and clinical significance. Statistical significance, often determined by the P value, marks an initial step in forming conclusions, suggesting that the observed difference or association is unlikely to be due to chance alone.[3] Some confusion arises because many people tend to equate “significance” with its everyday meaning of “importance”. Furthermore, in the field of medical research, this term may occasionally be open to interpretations that can result in misunderstandings or misrepresentations.[2,4]

On the other hand, clinical significance shifts its focus toward the tangible or meaningful implications of a discovery in real-life situations. This aspect determines whether a study’s findings are poised to influence current medical practices. Grasping the differentiation between these two principles proves crucial for precise data interpretation and well-informed decision-making across diverse domains, including medicine, public health, and the social sciences.[3]

Achieving a harmonious equilibrium between statistical significance and clinical relevance, while merging both perspectives, empowers health researchers and practitioners to establish conclusions that not only are statistically robust but also carry practical significance. This dual approach can effectively enhance the well-being of individuals and communities.[3,5]

What is statistical significance?

In the realm of medical research, the complexity of human factors and their intricate interactions within the natural environment poses formidable challenges when it comes to accurately predicting health outcomes and establishing clear cause-and-effect relationships.[1] Consequently, scientists across various health disciplines encounter significant hurdles when attempting to connect positive health outcomes with specific protective or risk factors. Furthermore, the majority of observational and experimental methods are inherently flawed, susceptible to random errors, human biases, and mistakes.[3,6]

In nearly all fields of scientific investigation, similar obstacles emerge, and the decision-making process often carries a prevailing element of uncertainty. To minimize the potential influence of subjective intuition, the scientific community and its practitioners rely on the concept of probability as a foundational tool. Probability serves as a quantitative measure for assessing the likelihood of particular events or results.[4,7] Through the application of this concept, scientists aim to introduce objectivity and rigor into their analytical frameworks, thereby fostering a more robust and dependable approach to scientific inquiry and decision-making. Probability calculations enable them to describe past occurrences and forecast future outcomes in comparable scenarios. These probabilities enable healthcare professionals, researchers, and policymakers to make well-informed judgments and predictions within the field of medicine.[1,4]

Let us consider this scenario in the area of medical research: Investigators are engaged in a study aimed at determining the efficacy of a novel drug in the treatment of a specific disease. In the initial stages of most clinical research endeavors, a question is formulated. In this particular case, the question at hand is whether drug X exhibits greater effectiveness in treating disease A when compared to a placebo. To address this inquiry, it becomes necessary to convert the research question into a testable hypothesis, commonly referred to as the null hypothesis, denoted as H₀. The null hypothesis generally assumes the following structure: H₀: Drug X lacks effectiveness in treating disease A (equivalent to the placebo’s effect). Subsequently, the research hypothesis, denoted as H₁, is formulated as follows: H₁: Drug X is a more efficacious treatment for disease A than the placebo.

In the subsequent step, they opt for a cohort of 500 patients afflicted with the disease and employ a random allocation process to divide them into two groups: one receiving the treatment and the other serving as a control. After administering the drug to the treatment group and providing a placebo to the control group, they carefully monitor the patients over a specified duration. Upon concluding the study, they perform a comparative analysis of the outcomes observed in both groups to gauge the drug’s efficacy. To scrutinize the results, the researchers undertake the calculation of the probabilities associated with specific events. For instance, they assess the likelihood of patients in the treatment group experiencing a positive response to the drug, the likelihood of patients in the control group experiencing a positive response to the placebo, and the likelihood of patients in either group encountering adverse effects. Through these probability calculations, researchers can quantify the chances of diverse outcomes and evaluate the statistical significance of their discoveries.[4] Statistical significance, in this context, pertains to the probability that an observed difference in efficacy or the presence of adverse effects in the study is not a consequence of random chance. This determination is made through various statistical tests such as the z-test, t-test, Chi-square test, and so forth. Typically, it is expressed as a P value, with results deemed statistically significant when the P value is less than 0.05, indicating the researcher’s decision to reject the null hypothesis. Such a rejection implies that the observed effect or association is unlikely to have arisen solely by chance.[1,2,4]

In simpler terms, if the P value in the given example is 0.04, it means that there is a 4% chance of observing the observed data or more extreme outcomes if there were truly no efficacy difference between the groups being compared. This leads to the rejection of the null hypothesis (drug efficacy is similar to placebo) and the acceptance of the research hypothesis (drug efficacy is better than placebo), indicating that the difference in drug efficacy is unlikely to be attributed to random chance alone.[3,4] Therefore, the statistically significant result indicates that the disparity in treatment outcomes is more likely due to the effectiveness of the treatment rather than random fluctuations. This information helps determine whether the drug is effective, if there are any potential side effects, and guides medical decision-making.

Therefore, statistical significance grasps its own importance in the area of medical research data analysis as it empowers researchers to have confidence in their findings and draw informed conclusions based on the results. Nevertheless, it is crucial to recognize that statistical significance, on its own, does not encompass the entirety of the narrative. To arrive at a comprehensive understanding of reality and formulate precise conclusions, one must delve into other facets and dimensions.[6,7]

What is clinical significance?

While statistical significance emphases on the likelihood of an observed effect being non-random, clinical significance considers whether the observed effect or relationship is significant enough to warrant attention and action in clinical practice. In other words, clinical significance relates to the practical or meaningful impact of a finding in a real-world context, and it focuses on whether the observed difference or relationship is large enough to be considered important or relevant from a clinical or practical standpoint.[3,8] For example, imagine the aforementioned study evaluates the effectiveness of a new medication (drug X) for treating depression. After analyzing the data, researchers find a statistically significant difference in depression scores between the medication group and the placebo group. However, when examining the effect size, it is discovered that the magnitude of improvement is minimal and may not translate into a noticeable change in patients’ well-being or functioning. In this case, although the statistical analysis indicates a significant effect, the clinical relevance may be questioned due to the lack of meaningful practical impact.[6]

On the flip side, clinical importance may still be evident in cases where statistical significance cannot be attained. Let us take another example for a study aims to investigate the effectiveness of a new therapy for managing chronic pain. The study includes a large sample of participants and divides them into two groups: the treatment group receiving the new therapy and the control group receiving a placebo. After analyzing the data, the researchers find that there is no statistically significant difference in pain reduction between the treatment group and the control group. The P value is above the predetermined threshold for statistical significance (e.g., P > 0.05). Based on statistical criteria alone, it would be decided that the therapy did not show a significant effect in reducing pain compared to the placebo. However, upon closer checkup of the data and considering the clinical significance, the researchers observe that although the difference in pain reduction between the groups did not reach statistical significance, there is a noticeable and meaningful enhancement in pain levels among the participants in the treatment group. This enhancement may not be statistically significant due to factors such as high variability or a small effect size, but it could still be clinically meaningful in terms of providing some relief or improving the quality of life for individuals experiencing chronic pain.[3,6,9]

Furthermore, clinical significance extends beyond mere magnitude of change to encompass a range of critical considerations. These factors encompass evaluating whether the change holds a substantial influence on individuals’ lives, assessing the duration of the effects, gauging acceptance by consumers, weighing cost-effectiveness, and examining the feasibility of implementation.[10] Once clinical relevance meets the aforementioned criteria, it becomes pivotal for healthcare professionals as it serves as a guiding factor in decision-making and determines the importance of research findings in relation to their potential benefits for patients and overall healthcare outcomes.

Which is more important, statistical or clinical significance?

The interplay between statistics and medical research often leads to discussions regarding the relative importance of statistical significance versus clinical significance in studies that yield either clear positive or negative outcomes. Ideally, researchers aim for findings that exhibit both statistical and clinical significance. Nevertheless, it is entirely possible to obtain statistically significant results that lack clinical meaning or, conversely, to have clinically meaningful outcomes that are not statistically significant.[3,6,11]

The emphasis on statistical significance versus clinical relevance can fluctuate depending on the specific context of a research study and how the findings will be applied. Consequently, different research questions may prioritize different aspects of significance. For instance, in a purely exploratory study designed to uncover potential associations or patterns, statistical significance might take precedence. Researchers would focus on determining whether observed differences or relationships hold statistical significance, which would guide further investigation or hypothesis generation.[6,8]

On the contrary, in a study aimed at informing clinical decision-making or shaping public health policies, such as assessing the efficacy of a new treatment or vaccine, clinical relevance assumes a paramount role. The primary focus here is to ascertain whether the observed effect or relationship holds significance in terms of its impact on patients’ health outcomes or the well-being of the population.[8,9] In such cases, clinical significance takes precedence due to the direct implications for healthcare and public health practices.

In each case, researchers should carefully interpret the findings and consider factors such as effect sizes, individual responses, side effects, patient preferences, and overall clinical judgment. Even if the statistical analysis did not demonstrate a significant difference, the observed clinical improvement may warrant further investigation, refinement of the therapy, or consideration of alternative statistical approaches.[7,11]

Furthermore, when researchers engage in hypothesis testing and make decisions regarding statistical and clinical significance, it is crucial to consider and be aware of the possibility of Type I and Type II errors when accepting or rejecting the null hypothesis.[2,11] Type I errors, also known as false positive results, occur when a statistical test indicates a significant difference between groups, but no clinically important difference actually exists. This means that the null hypothesis, which assumes no effect or difference, is rejected in error. On the other hand, Type II errors, or false negative results, occur when there is a clinically important difference between groups, but the statistical test fails to detect it or does not reach statistical significance. In these cases, the null hypothesis is accepted in error. Type II errors often arise when the sample size is small, leading to reduced statistical power.[1,6] To strike a balance between statistical and clinical significance and to minimize the risk of both Type I and Type II errors, researchers must meticulously consider the appropriate level of statistical significance, ensure an adequate sample size, and assess the clinical implications of their findings. By doing so, researchers can draw meaningful conclusions from their studies while justifying the possibility of incorrect interpretations or decisions.[3,6,10,11]

What are the current challenges and controversies?

In the field of healthcare investigation, the predominant reliance on P values has led to ongoing debates and controversies surrounding the issue of statistical and clinical significance. There have been calls to explore alternative approaches and move beyond P values. Recently, over 800 scientists from various fields, including statisticians, clinical and medical researchers, biologists, and psychologists, joined forces to challenge the concept of statistical significance and its misleading interpretation.[12,13]

The philosophy underpinning hypothesis testing raises several issues that warrant exploration. First, it is important to note that the capacity to refute hypotheses is limited to the realm of pure mathematics and does not readily translate to practical real-world situations. Simply failing to reject the null hypothesis does not automatically translate to accepting the null hypothesis as there may still be genuine effects in play.[1,11] It is crucial to recognize that in the real world, true effects are never precisely zero, rendering the assumption of a null hypothesis perpetually inaccurate. Consequently, adopting the position that effects are non-existent until proven otherwise can be seen as illogical and, in certain cases, impractical or even ethically problematic. Additionally, the commonly used significance level of 0.05 in hypothesis testing lacks a robust scientific foundation and is, therefore, essentially arbitrary in nature.[1,6]

To enhance the prudent utilization of P values, the American Statistical Association has issued six fundamental statements:

1. P values can be indicative of the level of discrepancy between the data and a specific statistical model.

2. P values do not quantify the probability of the tested hypothesis being true or the probability of the data resulting solely from random chance.

3. Making scientific conclusions or business/policy decisions solely based on whether a P value surpasses a specific threshold is not advisable.

4. Proper inference necessitates complete reporting and transparency of all relevant information.

5. A P value, or statistical significance, does not gauge the magnitude of an effect or the significance of a finding.

6. In isolation, a P value does not serve as a reliable measure of evidence regarding a model or hypothesis.[14]

To enhance the integration of statistical significance with clinical relevance, experts recommend the inclusion of supplementary measures such as transparent reporting of effect sizes and confidence intervals, along with their clinical interpretation. Effect sizes serve to quantify the magnitude of observed effects or relationships, offering a standardized measure of practical significance. This enables clinicians and patients to gain a better grasp of the magnitude and clinical relevance of findings, facilitating informed decision-making in clinical practice. Cohen’s d, or the d-value, quantifies differences between means in quantitative data studies. It is computed by dividing mean differences by pooled standard deviations. Larger d-values signify greater effect sizes, indicating substantial impacts on outcomes. Benchmarks suggest 0.2 as small, 0.5 as medium, and 0.8 as large effects. Researchers use Cohen’s d to gauge treatment effectiveness, such as comparing health measure means between drug and control groups.[15]

The number needed to treat (NNT) is another important measure for assessing treatment effects, representing different perspectives. Widely utilized in evidence-based medicine, it serves as a metric for effectiveness. NNT signifies the average number of patients who must undergo treatment to prevent an additional adverse outcome or for one patient to experience a beneficial outcome compared to a control group.[4,7]

Furthermore, it is imperative to take into account the study’s limitations when interpreting its findings. Several factors can influence the generalizability and applicability of results, including the specific demographic under investigation, the sample selection process, the study’s duration and setting, and the methods of data collection. Each of these variables can introduce biases or constraints that may impact both the statistical and clinical significances of the findings. By critically assessing the study’s limitations, researchers can offer a more nuanced interpretation of the results and pinpoint areas for potential improvement in future research.

CONCLUSION

In conclusion, both statistical significance and clinical relevance are crucial when interpreting research data in medical research. Statistical significance is concerned with determining the probability of an observed effect being non-random, making it particularly important in certain types of studies. On the other hand, clinical relevance assesses the practical impact of the findings in real-world settings, indicating the clinical benefits of medical interventions.

Ideally, researchers should strive for findings that are not only statistically significant but also incorporate additional measures such as effect sizes, confidence intervals, and their clinical interpretation. This comprehensive approach allows for a better understanding of the findings and ensures that they have both statistical and clinical significance, leading to meaningful and actionable results. However, it is possible to have results that are statistically significant but lack clinical significance, or vice versa.

Furthermore, it is crucial to consider the limitations of the study when interpreting the results and to critically evaluate the study’s design and potential biases. Through these efforts, researchers can enhance the robustness and reliability of their research, while also successfully translating their results into practical applications that benefit individuals and communities.

Highlights section

• Existing Knowledge: Medical research involves understanding statistical and clinical significance, encompassing challenges in reconciling evolving biomedical literature and potential misinterpretation in evidence-based medicine.

• Research Contribution: This article illuminates the interplay between statistical and clinical significance in medical research, highlighting their importance and potential pitfalls.

• Implications: Balancing statistical rigor and clinical relevance improves confident conclusions, aiding decision-making for medical interventions, but challenges persist in defining significance and addressing biases.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.